Sales 2024 by Business Segment

See more © MarketScreener.com

Sales 2024 by Geography

See more © MarketScreener.com

Historical Breakdown of Revenue by Business Segments

Operating Income: Breakdown by Business Segment

Breakdown by Business Segment (USD)
Fiscal Period: December2015201620172018201920202021202220232024

Veterinary Drugs

          

United States (U.S.)

3.56B 4.04B 4.31B 4.56B 5.07B

Gross Profit

2.85B 3.25B 3.51B 3.66B 4.14B

D&A

55M 54M 55M 80M 85M

Operating Income

2.24B 2.57B 2.76B 2.86B 3.34B

International

3.04B 3.65B 3.68B 3.91B 4.1B

Gross Profit

2.06B 2.55B 2.6B 2.68B 2.79B

D&A

56M 74M 86M 92M 96M

Operating Income

1.55B 1.95B 1.99B 2.04B 2.12B

Unallocated Contract Manufacturing & Human Health

83M 82M 86M 78M 80M

D&A

199M 175M 159M 153M 140M

D&A

- - - - -

D&A

3M 2M 5M 5M 5M

Operating Income

-339M -311M -379M -291M -309M

D&A

101M 115M 132M 128M 128M

Pharmaceutical Contract Manufacturing Services

          

Other Business Activities

- - - - -

D&A

27M 28M 28M 33M 43M

Operating Income

-372M -406M -424M -496M -562M

Geographical Revenue Distribution History

Geographical breakdown of sales (USD)
Fiscal Period: December2015201620172018201920202021202220232024

United States (U.S.)

3.56B 4.04B 4.31B 4.56B 5.07B

Total Assets

1.49B 1.64B 1.82B 2.09B 2.25B

Other Emerging Markets

656M 778M 758M 784M 865M

Other Developed Markets

388M 467M 468M 512M 564M

Brazil

258M 312M 330M 393M 414M

Australia

207M 259M 289M 323M 319M

United Kingdom

178M 234M 235M 277M 314M

Canada

210M 232M 238M 255M 277M

China

266M 357M 382M 320M 270M

Germany

159M 183M 176M 202M 225M

Mexico

116M 133M 136M 162M 169M

France

118M 132M 126M 142M 156M

Japan

177M 186M 173M 158M 147M

Spain

112M 128M 118M 122M 130M

Italy

90M 115M 111M 121M 129M

Chile

100M 136M 141M 140M 123M

Unallocated

83M 82M 86M 78M 80M

Other

- - - - -

Total Assets

716M 784M 933M 1.11B 1.14B